Introduction                                                    

The majority of patients with fecal incontinence due to a simple defect of the external anal sphincter will benefit from direct (overlapping) sphincter repair. Larger sphincter defects resulting from obstetric, surgical or other trauma are candidates for new treatment options such as skeletal muscle transposition (1,2) or the application of an artificial bowel sphincter (3), which will markedly improve the situation in up to 75-80% of patients.

However, a considerable number of patients with severe fecal incontinence will not show any structural defect of the external or internal anal sphincter on endo-anal ultrasonography or magnetic resonance imaging and have been described as patients with so-called idiopathic incontinence in the past.

In this group with primary degeneration and weakness of the anal sphincter and the pelvic floor as well as in patients with fecal incontinence due to spinal injury and other neurological disorders, treatment options have been limited so far.

Chronic sacral nerve stimulation (SNS) has been proposed for selected forms of non-neurogenic and neurogenic bladder dysfunction, mainly due to the reduction of the contractility of the detrusor during electrostimulation (4,5).

During stimulation, two different reflex arcs are believed to be activated via excitation of S2-S4 afferents. Sympathetic hypogastric activity is increased and parasympathetic activity of the lower motoneuron of the bladder is reduced. This dual effect is used for the treatment of detrusor hyperactivity.

Based on various studies in the past, SNS is an accepted treatment modality for urge incontinence as well as the pelvic pain syndrome (6).

Additionally, electrostimulation has been extensively researched to improve micturition in spinal cord patients (7) . Anorectal side effects during this treatment for urinary incontinence consisted of an increase in anal sphincter as well as colonic motility.

In contrast to the extensive experience gained with SNS for urologic indications, reports concerning the application of this modality for fecal incontinence are limited. The largest series published so far consists of 9 evaluable patients and was presented by Vaizey and co-workers . The patients were mainly treated for fecal incontinence due to weakness of the anal sphincters while one patient was treated for incontinence following a pull-through procedure after anal atresia and a  significant reduction of the number of incontinence episodes was registered in 7 of 9 patients.

Since intramuscular stimulation of an insufficient anal sphincter had been attempted as late as in the sixties of this century , the application of SNS in patients with a weak anal sphincter or neurologically caused incontinence seemed to be an interesting new therapeutic approach. Preliminary reports showed promising data for SNS in patients with therapy-refractory fecal incontinence, because of which this treatment was introduced at our institution.

Preoperative Evaluation
 

All patients have to undergo extensive pre-operative evaluation including clinical inspection, the completion of a standardized incontinence diary over a period of three weeks, anal sphincter manometry and endoanal ultrasound and/or magnetic resonance imaging.

A saline retention test after the application of  saline at a volume causing the first urge for defecation  is performed and the maximal time span from the end of instillation to the first evacuation of saline was documented.

Subjects  are regarded as candidates for SNS if they presented a minimum of one incontinence episode per week during the three-week observation period documented in their continence diary. Furthermore, no structural defects have to be observed in the external anal sphincter either on endoanal ultrasound or on MRI. Failed treatment with a 6-week course in bio-feedback must also be reported in all patients.

Patients with neurologically caused incontinence have to present a minimal history of one year in order to exclude patients with a spontaneous recovery following trauma or spinal cord surgery.

 

Technique of sacral nerve stimulation

 

Under general or local anesthesia, four to six needles  are positioned into the foramina S2 to S4 bilaterally, and stimulation is performed by the use of an external pulse generator (Screener, model 3625, Medtronic, Minneapolis, Minnesota, USA).

The muscular response of the pelvic floor and the anal sphincters is evaluated visually with both buttocks fixed firmly in order to differentiate pelvic floor response from a possible gluteal contraction. Additionally, intraoperative anal manometry or EMG can be  performed.

Following a positive stimulation response of the pelvic floor and/or the anal sphincters, the subsequent procedure of SNS is performed according to the recommendations for urological  indications. In order to evaluate the functional relevance of positive electric stimulation, a percutaneous nerve evaluation (PNE) is performed by application of a temporary stimulation wire which is introduced into the stimulation needle and fixed to the skin.

The functional result of stimulation is recorded over a period of 10 - 21 days and is followed by a final saline retention test. Patients whose continence status improves undergo permanent implantation of a pulse generator  (INTERSTIM, Medtronic, Kerkrade, Netherlands). During this procedure the permanent electrode is implanted at the site of the external stimulation wire and then connected to the subcutaneous pulse generator by application of an extension kit.   

Recent results

 

 

Acute (needle) testing revealed a typical positive visual response (i.e. contraction of the pelvic floor in a cranial-ventral direction and circular contraction of the anal sphincter) in 16 patients who underwent  subsequently permanent implantation. In 4 patients (fecal incontinence following spinal cord trauma after a car accident: 2 , spinal stroke, and meningomyelocele) the acute testing failed to show any response.  

Functional results

 

All patients who had shown a positive visual response during acute testing  and who had received a permanent implant revealed a marked reduction in their incontinence episodes as well as an increase in the time span during saline retention tests .

The median number of incontinence episodes for solid or liquid stool per 21 days decreased from 6 episodes (3 – 15 / 21 days) to  2 (0 – 5 / 21 days) in the total series of 16 implanted patients. Patients (n:4) with idiopathic incontinence revealed 3,3,4,and 6 episodes respectively preoperatively compared with  0,0,0, and 2 episodes postoperatively. The median number of incontinence episodes in neuro patients (n: 12) was preoperative  7 (4  - 15) and postoperative 2 (0 – 5) (p < 0.01) .

The time period of retention of  a volume of saline causing an urge  until definitive defecation was preoperative 2 min (0 – 5 min) and raised to 7.5 min ( 2 – 15 min). In idiopathic patients the preoperative measurements were 2,2,5,and 7 minutes and (postoperative) 2, 10,10,and 15 minutes, respectively.

In the group with neurological incontinence the preoperative retention test revealed a median time of  2 min (0-5 min ) compared with 7 min (2 – 15 min) (p< 0.01) .

As the most prominent observation, patients with neurologically induced incontinence and two patients with idiopathic incontinence  reported a restoration of their anal sensory function. This consisted of an improvement in the sensory capacity of the rectum ampulla as well as the restoration of sensory function perianally  and the perineal skin.

This was nicely shown by two patients in the idiopathic group who did not report any feeling in the rectum  up to the maximal distension of the balloon (i.e. 300 ml) and who reported a complete recovery of their sensory function following SNS  

Three patients who had to undergo a complete explant of the stimulation system due to infections (one patient with meningomyolocele, one with Friedreich’s ataxia and one with idiopathic incontinence) reported an immediate deterioration of their continence function following explantation of the system. After  of the infectious situation, all of them were rated as candidates for renewed sacral nerve stimulation. Until the control date (Mar. 1, 2001) one patient underwent a successful reimplantation  while two others are still waiting for a new SNS.

Discussion

 

Contrary to other reports, the main indication in our series was incontinence of neurological origin (n: 15), usually following spinal cord trauma or as a complication after spinal cord surgery for protrusion. While 4 patients showed no pelvic floor and/or anal sphincter response during acute testing, 15 patients achieved a marked improvement or even complete restoration of their continence status, as shown by a reduction in the number of incontinence episodes per week as well as by an increase in the retention time.

The positive stimulation response during acute testing was confirmed visually by the typical contraction features of the pelvic floor and the anal sphincters and significant changes in postoperative anal manometry (3 months postoperatively) were observed.  We were able to demonstrate a significant increase in sphincter pressures and anal canal length which we attribute to the larger number of patients (compared to previous publications) in our series.

Neuromodulation of sacral reflexes and regulation of rectal sensitivity appear to be the major reasons for the functional improvement in our neurological patients following SNS. Although difficult to objectify by diagnostic instruments, all patients showed a successful response, and reported a marked improvement in their rectal sensory function as well as in perianal and perineal sensitivity. Especially in patients following spinal cord trauma in the lumbar region (L1 to L5) , the notion of overcoming the neurological defect by a more distally applied stimulation is a novel approach. Neurophysiologic investigations like pudendal nerve latency measurement which might be able to demonstrate the effects of SNS were not performed in our series. Beside the lack of equipment for these procedures at our institutions these investigations have always been restricted to very specialized departments and have been criticized  for their interobserver variability as well as their limited clinical relevance.

Our preliminary experience showed that the surgical management of patients with fecal incontinence might differ considerably from that of urological patients. While an effective influence of SNS on the urinary bladder can only be evaluated during an observation period of 2-3 weeks involving repeated measurements of the residual bladder volume , a typical positive response to external stimulation during acute testing in fecal incontinence was associated with improved function in almost all of our patients reported in this series. Furthermore, 3 patients developed severe infection of the implanted material, which led to explantation of the stimulation system despite a positive influence on continence function; the infection had probably occurred during the external stimulation  process. Therefore, we altered our concept to an immediate implant during a one-stage procedure following a positive pelvic floor/and or sphincter response after needle stimulation.

Referring to the concerns regarding the implantation of a cost-intensive system and the potentially inadequate functional outcome, it should be emphasized that all patients in the present series had severe fecal incontinence that was therapy refractory to other treatment modalities. In the past, most of the patients with such severe incontinence had been candidates for dynamic graciloplasty at our institution . This means that, in the event of an unsatisfactory functional outcome despite a positive pelvic floor response during acute  testing , the patient would be a candidate for dynamic graciloplasty, which could be applied by using the previously implanted pulse generator.

We conclude that, in our very preliminary experience, sacral nerve stimulation has shown promising results in the treatment of fecal incontinence of neurological etiology as well as due to an idiopathic diffuse weakness of the pelvic floor. Although a longer follow-up is mandatory to assess the long-term efficacy of this method, the initial promising results warrant further clinical studies focusing on this new modality. 

Literature

 

  1. Madoff RD, Baeten CGMI, Christiansen J,  et al. Standards for anal sphincter replacement. Dis Colon Rectum 2000; 43:135-141

  2. Baeten CGMI, Geerdes BP, Adang EMM, Heineman E, et al. Anal dynamic graciloplasty in the treatment of intractable fecal Incontinence. N Engl J Med 1995; 332:1600-1605

  3. Wong WD, Jensen LL, Bartolo DCC, Rothenberger DA. Artificial anal sphincter. Dis Colon Rectum 1996; 39: 1345-1351

  4. Thon WF, Baskin LS, Jonas U, et al. Neuromodulation of voiding dysfunction and pelvic pain. World J Urol 1991; 9:138-141

  5. Bosch JLHR, Groen J. Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 1995; 154:504-507

  6. Weil EHJ, Riuz-Cerda JL, Eerdmans PHA, et al. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol 1998; 16: 313-321

  7. Ishigooka M, Suzuki T, Hashimoto I, Sasagawa I, Nakada T, Handa Y. A new technique for sacral nerve stimulation: a percutaneous method for urinary incontinence caused by spinal cord injury. Br J Urol 1998; 81:315-318

  8. Caldwell KPS the electrical control of sphincter incompetence. Lancet 1963; 2: 174 - 177

  9. Matzel KE, Stadelmaier U, Hohenfellner M. Gall FP. Electrical stimulation of spinal nerves for treatment of fecal incontinence. Lancet 1995;346:1124-1127

  10. Vaizey CJ, Kamm MA, Turner I, et al. effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinence. Gut 1999; 44:407-412

  11. Malouf AJ, Vaizey CJ, Nicholls J, Kamm MA. Permanent  sacral nerve stimulation for fecal incontinence. Ann Surg 2000; 232:143-148

  12. Rosen HR, Novi G, Zöch G, Feil W, Urbarz C, Schiessel R. Restoration of anal sphincter function by single-stage dynamic graciloplasty with a modified (split sling) technique. Am J Surg 1998;175:187-193